ZURA a med tech microcap with catalysts LONG

Updated
ZURA a penny stock has catalysts- an FDA action is soon upcoming and an insider bought a lot

more shares. The 120-minute chart shows a solid trend up since earnings March 28th. This

pre-revenue company beat earnings with less cash burn than expected. Another earnings

report is about a month away. Price has settled to the support of the longest EMA line.

I see an opportunity here for a long trade toward the earnings in a month. The longer black RSI

line above the 50 level while the shorter green line shows the oversold undervalued condition

for an entry.
Note
Price moved down a bit. Holding a full position and patient.
Note
Reversed the move down and more or less sideways.
emacloudstrategyLABMoving AveragespillXBIZURA

Disclaimer